Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations

NCT02995733 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT02995733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02995733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 27, 2017
Completion date
April 30, 2021
Enrollment
1,220 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

asthma